Risperidone safety in pregnancy. A case report

Actas Espanolas de Psiquiatria

Volumn 36, Issue 6, 2008, Pages 366-368

  Rodríguez Salgado, Beatriz ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Antipsychotic drugs; Pregnancy; Psychosis; Risperidone

Indexed keywords

NEUROLEPTIC AGENT; RISPERIDONE;

ARTICLE; CASE REPORT; DRUG EFFECT; FEMALE; FETUS DEVELOPMENT; HUMAN; MIDDLE AGED; PREGNANCY; PSYCHOSIS; RISK FACTOR;

ANTIPSYCHOTIC AGENTS; FEMALE; FETAL DEVELOPMENT; HUMANS; MIDDLE AGED; PREGNANCY; PSYCHOTIC DISORDERS; RISK FACTORS; RISPERIDONE;

EID: 57349138518     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Grigoriadis S, Seeman MV. The role of estrogen in schizophrenia: implications for schizophrenia practice guidelines for women. Can J Psychiatry 2002;47:437-42.
2. Nilsson E, Lichtenstein P, Cnattingius S, Murray RM, Hultman CM. Women with schizophrenia: pregnancy outcome and infant death among their offspring. Schizophr Res 2002;58:221-9.
3. Seeman MV. Gender differences in the prescribing of antipsychotic drugs. Am J Psychiatry 2004;161:1324-33.
4. Newport DJ, Fisher A, Graybeal S, Stowe ZN. Psicofarmacologia durante el embarazo y la lactancia. In: Schatzberg AF, Nemeroff CB. Tratado de psicofarmacologia. Barcelona: Masson, 2006; p. 1261-2.
5. McKenna K, Koren G, Tetelbaum M, Wilton L, Shakir S, Diav-Citrin O, et al. Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. J Clin Psychiatry 2005;66:444-9.
6. Newport DJ, Calamaras MR, DeVane CL, Donovan J, Beach AJ, Winn S, et al. Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes. Am J Psychiatry 2007;164:1214-20.
7. Gentile S. Clinical utilization of atypical antipsychotics in pregnancy and lactation. Ann Pharmacother 2004;38:1265-71.
8. Coppola D, Russo LJ, Kwarta RF Jr, Varughese R, Schmider J. Evaluating the postmarketing experience of risperidone use during pregnancy:pregnancy and neonatal outcomes. Drug Saf 2007;30:247-64.
9. Ratnayake T, Libretto SE. No complications with risperidone treatment before and throughout pregnancy and during the nursing period. J Clin Psychiatry 2002;63:76-7.
10. Kim SW, Kim KM, Kim JM, Shin IS, Shin HY, Yang SJ, et al. Use of long-acting injectable risperidone before and throughout pregnancy in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:543-5.
11. Dabbert D, Heinze M. Follow-up of a pregnancy with risperidone microspheres. Pharmacopsychiatry 2006;39:235.
12. Zuo J, Liu Z, Ouyang X, Liu H, Hao Y, Xu L, Lu XH. Distinct neurobehavioral consequences of prenatal exposure to sulpiride (SUL) and risperidone (RIS) in rats. Prog Neuropsychopharmacol Biol Psychiatry 2007 Sep 15 (Epub ahead of print).
13. Aichhorn W, Whitworth AB, Weiss EM, Marksteiner J. Second-generation antipsychotics: is there evidence for sex differences in pharmacokinetic and adverse effect profiles? Drug Saf 2006;29:587-98.
14. Hill RC, McIvor RJ, Wojnar-Horton RE, Hackett LP, Ilett KF. Risperidone distribution and excretion into human milk: case report and estimated infant exposure during breast-feeding. J Clin Psychopharmacol 2000;20:285-6.
15. Ilett KF, Hackett LP, Kristensen JH, Vaddadi KS, Gardiner SJ, Begg FJ. Transfer of risperidone and 9-hydroxyrisperidone into human milk. Ann Pharmacother 2004;38:273-6.